SEWON E&C Co., Ltd. engages in the manufacture and sale of chemical plant equipment and machinery. It operates through the following businesses: Process Equipment, Power Limb and Regenerative Medical System. The Process Equipment business provides drums, reactors, heat exchangers, columns, and air cooled heat exchangers. The Power Limb business manufactures pump, valve, unit, cylinder, and others. The Regenerative Medical System division offers cell therapy, bio collage, and Regenerative Medical platform. The company was founded in 1971 and is headquartered in Changwon-si, South Korea.

NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark.

Consiglio Nazionale delle Ricerche is the largest public research facility in Italy. Founded in 1923, it has worked in the past as a government consultant on research and as a funding fund for university research grants. Since 1989 the CNR is a research institution, with the mission of carrying out research projects, promoting innovation and competitiveness of the national industrial system, the internationalization of the national research system, and providing technologies and solutions to emerging needs in the public and private sectors. . Objectives that are achieved through a wealth of human resources that has over 8000 employees, half of which is represented by researchers and technologists. About 4,000 young researchers are involved in post-doctoral research activities in the laboratories of the Institute, while an important contribution comes from collaborations, including international ones, with researchers from universities and companies, thus strengthening the national research system.

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

Coripharm Medizinprodukte GmbH & Co KG, part of aap Implantate AG, is a German company located in Dieburg. The firm develops bone substitute products. On November 30, 2000 aap Implantate AG acquired Coripharm Medizinprodukte GmbH & Co KG.

FivePrime is dis­cov­er­ing and devel­op­ing novel ther­a­peu­tic pro­teins and anti­bod­ies by sys­tem­at­i­cally screen­ing all rel­e­vant pro­teins in the human body to find the best pro­tein for treat­ment of a given clin­i­cal indi­ca­tion. FivePrime’s Pro­Screen Engine enables the rapid pro­duc­tion and screen­ing of all ther­a­peu­ti­cally rel­e­vant pro­teins in medically-​​focused assays at the high­est qual­ity stan­dards in the indus­try. This pow­er­ful approach is the polar oppo­site of the industry’s tra­di­tional “one pro­tein at a time”. The Pro­Screen Engine com­prises the defin­i­tive pro­tein col­lec­tion and screen­ing process for bio­log­ics dis­cov­ery and is unprece­dented in its effi­ciency, qual­ity, and scale. In addi­tion to DBL Investors, investors include Domain Asso­ciates, Ver­sant Ven­tures, Kleiner Perkins Cau­field and Byers, Texas Pacific Group, Health­Cap, and Advanced Tech­nol­ogy Ventures.

MedX Health Corp. engages in the development, manufacture, and sale of medical device and software. It offers SIAscopy on DermSecure telemedicine platform, which is used to scan skin for suspicious moles and lesions, and phototherapeutic medical devices. Its brands include the DermSecure, MoleMate, SIMSYS, and SIAMETRICS. The company was founded on April 15, 1999 and is headquartered in Mississauga, Canada.

Shanghai Blue Derivatives Technology Co., Ltd., established on 2018-11-26, The scope of business includes engaging in biotechnology,new material technology,3D printing technology,Technology development in the field of computer and software and hardware technology,technical consulting,Technical Services,technology transfer,account Serive,computer system integration,computer,Software and Auxiliary Equipment,Instrumentation,Mechanical equipment and accessories,metallic material,electronic product,Sales of Class I Medical Devices. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Zhejiang Xingyue Biotechnology Co., Ltd., established on 2010-04-19, Business scope includes general items:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Engineering and Technology Research and Experimental Development;New material technology promotion service;Technology Import and Export;Import and export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Non-residential real estate leases;property management;Chemical product sales(No licensed chemical products);Biochemical product technology research and development;Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Medical Research and Experimental Development;Manufacturing of bio-based materials;Sales of bio-based materials;Cosmetics Wholesale;Cosmetics Retail;Research and development of bio-based materials technology;Manufacturing of daily chemical products;Sales of daily chemical products;Manufacture of special equipment for daily chemical industry;Pharmaceutical commissioned production(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;pharmaceutical production;Cosmetic production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

TissUse is a Berlin, Germany-based, vibrant growth company who has developed a unique "Multi-Organ-Chip" platform that - for the first time ever - provides preclinical insight on the systemic level using human tissue. This enabling technology platform consists of a miniaturized construct that closely simulates the activity of multiple human organs in their true physiological context. TissUse's Multi-Organ-Chips provide a completely new approach to predict, for example, toxicity, ADME profiles and efficacy in vitro, reducing and replacing laboratory animal testing and streamlining human clinical trials.

Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. Its products include cordycepin, metallothionein, marine elements, embryonic nutrients, and active compound of antodia cinnamomea. The company was founded on September 24, 2014 and is headquartered in Fishers, IN.

Korea Institute of Machinery & Materials is a research institute funded by the government.

Xi'an Dexin Zhixing Enterprise Management Consulting Co., Ltd., established on 2014-09-25, Business scope includes business management consulting;Marketing Planning Consulting;market research;Internal staff training;Business Consulting;account Serive;technical consulting;Human Resource Management Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Cellontech Co., Ltd. engages in the development and supply of computer systmes. Its products include computerized finger print recognition system and information technology infrastructure. The company was founded in 2000 and is headquartered in Seoul, South Korea.

Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Two Cells Co., Ltd. engages in the research, development, manufacture, and sales of therapeutic genes, cells, drugs, diagnostic agents, chemical reagent, and medical materials. It also offers manufacture and sale of medical appliances, instruments and software related to regenerative medicine. It also handles research and development of disease treatments and cell culture system. The company was founded on April 23, 2003 and is headquartered in Hiroshima, Japan.

Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia.